Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹593.25Admitted-Finance | ₹593.25 | L1 | Admitted-Finance |
| 2 | L2₹1,184.92Admitted-Finance | ₹1,184.92 | L2 | Admitted-Finance |
| 3 | Rejected-Technical BAYER HOUSE CENTRAL AVENUE HIRANANDANI ESTATE THANE MAHARASHTRA 400607 | THANE | THANE | MAHARASHTRA | 400607 | - | - | Rejected-Technical Non Responsive |
| 4 | Rejected-Technical | - | - | Rejected-Technical Non Responsive |
| Sl No | Description | Qty | Unit | GLS PHARMA LTD. L1 | UNITED BIOTECH PVT LIMITED L2 |
|---|---|---|---|---|---|
| 1.00 | Cyclophosphamide Inj IP 200 mg [138] | 23,400 | 10 ml glass Vial (Rate Should be quoted for Single Unit) | - | 28.5 ₹29.93 |
| 2.00 | Fluorouracil Inj IP 250 mg/ 5ml [148] | 1,25,689 | 5 ml Ampoule (Rate should be quoted Single Unit) | - | - |
| 3.00 | Methotrexate Tab IP 2.5 mg [154] | 6,66,108 | 10 x 10 Tab strip (Rate should be quoted for 100 tablet) | - | - |
| 4.00 | Vincristine Injection IP 1 mg [159] | 28,565 | Vial / Amp (Rate should be quoted Single Unit) | - | - |
| 5.00 | Atropine Eye Ointment IP 1% [319] | 76,657 | 3 gm tube in Mono carton (Rate should be quoted for single cartoon) | - | - |
| 6.00 | Ciprofloxacin Ophthalmic Ointment USP 0.3% [323] | 13,83,255 | 5 gm Tube in Mono Carton (Rate Should be quoted for Single Unit) | - | - |
| 7.00 | Inj. Ganciclovir Sodium 500mg (lyophilized powder for
reconstitution) [724] | 3,228 | Vial (Rate Should be quoted for single Vial) | - | 1,100 ₹1,155 |
| 8.00 | 3rd Generation Recombinant F VIII 250 IU with diluent [749] | 22,783 | Vial with diluents (Rate should be quoted for Single unit) | - | - |
| 9.00 | Leurprolide Acetate depot 3.75 mg [775] | 3,325 | Vial (Rate should be quoted for Single Unit) | 565 ₹593.25 | - |
| 10.00 | Gatifloxacin 0.30% and Prednisolone Acetate 1% Ophthalmic Suspension [NRD-103] | 1,09,486 | 10ml (Rate should be quoted Single Unit) | - | - |
Tender Value
₹10.8 Cr
EMD Value
₹21.6 L
Closing Date
11 Dec 2025, 6:00 pmClosed
MD RMSCL
Rajasthan Medical Services Corporation Limited, Gandhi Block, Swasthya Bhawan, Tilak Marg, CScheme, Jaipur-302005 (Raj.)
E-BID FOR RATE CONTRACT CUM SUPPLY AND EMPANELMENT OF FIRMS FOR DRUGS AND MEDICINES
2025_RMSCL_513367_1
RMSC/PRO/DRUG/NIB-11/2025/2931 Dt. 14.11.2025
Open Tender
Supply of Materials/Hiring of Goods
60 days
All Rajasthan
As Per Bid Document
4 documents required · 4 mandatory
₹2,360
Yes
MD RMSCL
₹21.6 L
Yes
RMSCL Board Room
2 Apr 2026
14 Nov 2025
12 Dec 2025
14 Nov 2025
11 Dec 2025
1 Dec 2025
21 Nov 2025
Cyclophosphamide Inj IP 200 mg [138]
Fluorouracil Inj IP 250 mg/ 5ml [148]
Methotrexate Tab IP 2.5 mg [154]
Vincristine Injection IP 1 mg [159]
Atropine Eye Ointment IP 1% [319]
Ciprofloxacin Ophthalmic Ointment USP 0.3% [323]
Inj. Ganciclovir Sodium 500mg (lyophilized powder for reconstitution) [724]
3rd Generation Recombinant F VIII 250 IU with diluent [749]
Leurprolide Acetate depot 3.75 mg [775]
Gatifloxacin 0.30% and Prednisolone Acetate 1% Ophthalmic Suspension [NRD-103]
HPMC 0.3% Eye Drop [NRD-104]
Voriconazole 1 % w/v (Lyophilized) 30mg Eye Drop [NRD-119]
Chloramphenicol 1%, Polymyxin B Sulphate (10000 Units) and Dexamethasone 0.1% Sodium Phosphate Eye Ointment [NRD-123]
Detemir Insuline 100IU/ml Injection 3ml [NRD-214]
Fludarabine Phosphate Injection 50mg Inj. IP [NRD-238]
Methotrexate 1000 mg Inj. IP [NRD-289]
Inj. Methylprednisolone Acetate 125 mg I.P. (Each vial contains Methylprednisolone Acetate 125 mg) [NRD-292]
Mitomycin 40 mg Inj. IP [NRD- 297]
Rasburicase 1.5 mg Inj. [NRD-347]
Recombinant LH 75IU Inj. [NRD-351]
Trypan blue 0.06% w/v Injection [NRD-393]
Levosalbutamol 50mcg. and Ipratropium 40mcg. MDI [NRD-425]
Glycopyrronium Inhalation Solution 25mcg 2 ml [NRD-458]
Amorolfine 0.25% Cream [NRD-46]
Glycolic Acid 6% Cream [NRD-51]
Hydroquinone 2% Cream USP [NRD-53]
Everolimus 10mg Tab./Cap. [NRD-531]
Dacomitinib 15 mg Tab.
Methimazole 10mg Tab. USP [NRD-678]
Rasagiline1MG Tab. [NRD-756]
Regorafenib 40 mg Tab. [NRD- 757]
Ulipristal 5mg Tab. [NRD-808]
Brinozolamide 1% w/v and Brimonidine Tartrate 0.2% w/v Ophthalmic Suspension [NRD-98]
Triclofos oral suspension500 mg/ 5ml in 30ml Syrup I.P. [NRD-522]
Etoricoxib+thiocolchicoside(60+8 mg) Tab. [NRD-630]
Levodopa and Carbidopa and Entacapone 100mg/25mg/200mg Tab. [NRD-662]
Nicorandil 5mg Tab. I.P. [NRD-704]
Nifidipine Capsule 10mg
Diastase, Pepsin with simethicone 15ml DropEach ml contains Diastase (1:1200) 33.33mg, Pepsin (1:3000) 5mg & Simethicone emulsion 40mg [NRD-71]
Nitazoxanide 500mg Tab. [NRD-713]
Hydroxyzine Hydrochloride Oral Solution / Drop 6mg/ml [NRD-76]
Trimetazidine Hydrochloride Modified Release (CR/SR/PR) 60 mg Capsule/Tablet [NRD-805]
Ferrous Ascorbate and Folic acid Drops 15ml (each ml contains Ferrous Ascorbate 10mg and Folic acid 100mcg) [NRD-81]
Zinc 50MG Tab. [NRD-818]
Vitamin – E 50mg/ml Drops 15ml [NRD-83]
stage.html
html • 0.03 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.25 MB
BOQ_915632.xls
BOQ • 0.38 MB
NIB11.pdf
Tender Documents • 23.88 MB
Download all tender documents and submit your bid